[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 30/11/2017 To : Hong Kong Exchanges and Clearing Limited Name of Issuer Huaneng Power International, Inc Date Submitted 01/12/2017 I. Movements in Authorised Share Capital 1. Ordi]
[Item 8.01 Other Events. non-controlling Effective upon the completion of the IPO on November 13, 2017, all of the Sogou shares held by Sohu were redesignated as Class B Ordinary Shares. Each Class B Ordinary Share is entitled to ten votes per share on any matter brought to a vote of Sogou shareholde]
[Item 8.01 Other Events. non-controlling Effective upon the completion of the IPO on November 13, 2017, all of the Sogou shares held by Sohu were redesignated as Class B Ordinary Shares. Each Class B Ordinary Share is entitled to ten votes per share on any matter brought to a vote of Sogou shareholde]
[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 30-11-2017 To : Hong Kong Exchanges and Clearing Limited Name of Issuer China Petroleum & Chemical Corporation Date Submitted 01/12/2017 I. Movements in Authorised Share Capital 1]
[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 30-11-2017 To : Hong Kong Exchanges and Clearing Limited Name of Issuer China Petroleum & Chemical Corporation Date Submitted 01/12/2017 I. Movements in Authorised Share Capital 1]
[XINYUAN REAL ESTATE CO., LTD. UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME O]
[Biostar Regains Compliance with NASDAQ Continued Listing Requirement XIANYANG, China, December 4, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) (“Biostar” or “the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced t]
[XINYUAN REAL ESTATE CO., LTD. UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME O]
